FDA's ANDA Approvals(5月23日)
公開日時 2011/05/25 04:00
FDA’s ANDA Approvals |
Applicant |
Active Ingredients |
Number |
Date Approved |
Dr. Reddy’s |
Venlafaxine HCl, EQ 37.5 mg base, EQ 75 mg base and EQ 150 mg base extended-release caps. |
78-421 |
5/10/2011 |
Barr |
Donepezil HCl, 5 mg and 10 mg orally disintegrating tabs. |
78-388 |
5/10/2011 |
Zydus |
Donepezil HCl, 5 mg and 10 mg orally disintegrating tabs. |
90-175 |
5/10/2011 |
Sandoz |
Donepezil HCl, 5 mg and 10 mg orally disintegrating tabs. |
91-198 |
5/10/2011 |
Vintage |
Dexamethasone, 0.5 mg/5 mL oral elixir |
91-188 |
5/11/2011 |
Vintage |
Ethinyl estradiol/levonorgestrel, 0.02 mg/0.1 mg oral-28 tabs. |
77-099 |
5/11/2011 |
Wockhardt |
Octreotide acetate, EQ 0.05 mg base/mL, EQ 0.1 mg base/mL and EQ 0.5 mg base/mL inj. |
90-985 |
5/11/2011 |
Wockhardt |
Octreotide acetate, EQ 0.2 mg base/mL and EQ 1 mg base/mL inj. |
90-986 |
5/11/2011 |
Coastal |
Bromfenac sodium, 0.09% ophthalmic solution/drops |
201-211 |
5/11/2011 |
Amneal |
Nitrofurantoin, 25 mg/5 mL oral suspension |
201-679 |
5/11/2011 |
Bioniche |
Irinotecan HCl, 20 mg/mL, 40 mg/2 mL (20 mg/mL) and 100 mg/5 mL (20 mg/mL) inj. |
90-393 |
5/13/2011 |
Paddock |
Sodium polystyrene sulfonate, 15 gm/60 mL oral rectal suspension |
90-590 |
5/13/2011 |
Mylan |
Budesonide, 3 mg caps. |
90-410 |
5/16/2011 |
Fresenius Kabi |
Gemcitabine HCl, EQ 2 gm base/vial inj. |
90-799 |
5/16/2011 |
APP |
Gemcitabine HCl, EQ 2 gm base/vial inj. |
90-242 |
5/17/2011 |
Cipla |
Risperidone, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg tabs. |
77-543 |
5/18/2011 |
Tentative Approvals |
|
|
|
Lupin |
Levetiracetam, 500 mg and 750 mg extended-release tabs. |
91-399 |
5/5/2011 |
Sandoz |
Brimonidine tartrate/timolol maleate, 0.2%/0.5% ophthalmic solution |
91-087 |
5/11/2011 |
Cipla |
Abacavir sulfate/lamivudine, 60 mg/30 mg suspension/tab. |
202-007 |
5/12/2011 |
Synthon |
Levocetirizine dihydrochloride, 0.5 mg/mL oral solution |
91-263 |
5/13/2011 |
Fresenius Kabi |
Gemcitabine, 200 mg and 1 g inj. |
90-799 |
5/16/2011 |
APP |
Gemcitabine, 200 mg and 1 g inj. |
90-242 |
5/17/2011 |
(The Pink Sheet 5月23日号より) FDAと米国製薬企業の情報満載 “The Pink Sheet”はこちらから